98%
921
2 minutes
20
Objective: Neuropsychological assessment among U.S. Arabic-speaking older adults is virtually non-existent due to lack of translated measures and normative data, as well as researchers' limited access to Middle Eastern/Arab Americans. The Montreal Cognitive Assessment (MoCA) is the only validated, widely-used dementia screen with Arabic language norms/cutoffs, yet, Arabic MoCA translations vary across countries and studies. We examined utility of a modified translation among Arabic-speaking immigrants in metro-Detroit.
Methods: The Arabic MoCA was modified to reflect consistency with the original English version while remaining meaningful in the Arabic language. The MoCA was then administered to 32 Arabic-speaking adults age 65 + living in metro-Detroit. Eight (25%) had an Alzheimer's disease or related dementia (ADRD) diagnosis. Each item was standardized and Cronbach's alpha assessed reliability. Ordinary least squares models examined whether an ADRD diagnosis predicts the total MoCA score and each item, adjusting for demographics.
Results: The mean age of the sample was 73 years old. The alpha was acceptably high at 0.87. Bivariate analyses show those with ADRD diagnosis scored lower overall on the MoCA. However, probability of diagnosis and age were confounded in the sample such that in multivariate analyses ADRD diagnosis did not explain additional variation beyond what is explained by age. Orientation, cube-copy test and serial 7s best distinguished those with ADRD.
Conclusion: The modified Arabic language MoCA shows promise distinguishing those with an ADRD diagnosis. This translation provides a resource for neuropsychologists looking for translated tests when working with Arabic-speaking patients in the U.S.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584311 | PMC |
http://dx.doi.org/10.1007/s10823-024-09513-w | DOI Listing |
JAMA Netw Open
September 2025
Department of Neurosciences, University of California, San Diego, La Jolla.
Importance: Subjective cognitive decline (SCD) may be an early indicator of Alzheimer disease and related dementias (ADRD), yet its association with plasma biomarkers remains unclear among middle-aged and older adults (aged 50-86 years).
Objective: To examine associations between plasma biomarkers of amyloid, tau, neuroaxonal damage, and glial activation with SCD in a heterogeneous cohort of Hispanic and/or Latino adults.
Design, Setting, And Participants: This cross-sectional study used survey-weighted data from the Study of Latinos-Investigation of Neurocognitive Aging, an ancillary study of the Hispanic Community Health Study/Study of Latinos.
Hawaii J Health Soc Welf
July 2025
Center on Aging, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa.
Health care workers with specialized knowledge and skills to work with people living with symptoms of dementia are needed in all sectors of the health care industry in Hawai'i as the number of people in the population diagnosed with Alzheimer's disease and related dementias (ADRD) is expected to increase along with the overall number of older adults (ages 65+). This article provides a scoping review of relevant population data that suggest an urgency to address this need even as the state contends with an overall shortage of workers throughout the public health and health care industry. The authors then provide practical solutions, recommending a multi-pronged approach to introduce or enhance dementia-care competencies at various levels of education - from high school to graduate or professional studies - and through continuing education and professional development programs for practicing health professionals.
View Article and Find Full Text PDFIntroduction: Alzheimer's disease (AD) remains a major neurocognitive disorder of global health significance. Globalizing ancestral diversity in AD genetics is essential to identify causal variants, improve diagnosis, and enable equitable therapeutic interventions across populations. The Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) initiative addresses this by including African ancestry and Hispanic/Latinx (HL) ancestry populations.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Department of Epidemiology & Biostatistics, Joe C. Wen School of Population & Public Health, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, Irvine.
Importance: Young-onset dementia (YOD), which develops before age 65 years, can bring additional challenges to patients and their caregivers. The prevalence of YOD and its associated comorbidities across US racial and ethnic populations remain unclear.
Objective: To estimate the prevalence of YOD and examine associations between comorbidities and YOD among Medicare beneficiaries in various racial and ethnic groups.
Int J Geriatr Psychiatry
August 2025
Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Objectives: In a sample of community-dwelling older adults, we examined the association of Alzheimer's Disease and Related Dementias (AD/ADRD) blood-based biomarkers (BBMs) and neuropsychiatric symptoms (NPS) and whether informant type (i.e., spouse vs.
View Article and Find Full Text PDF